What is it about?
Caffeine and Aminophylline are being used to treat apnea of prematurity over the years. Aminophylline less expensive drug used more commonly in developing countries and as effective as Caffeine. This article highlights about long term neurological outcome of preterm neonates with apnea of prematurity treated with either of the drug.
Featured Image
Why is it important?
Western world more familiar with use Caffeine citrate to treat Apnea of prematurity compared to Aminophylline which as equally effective and less expensive.
Perspectives
Extensive use of Caffeine in preterm neonates compared to Aminophylline could be partly due to Phrama-Industry promoted interventions Our experience clearly shows both drugs equally effective in treating apnea of prematurity,however Aminophylline less expensive and easily available.
Professor Leslie Edward Simon Lewis
KASTURBA MEDICAL COLLEGE MANIPAL
Read the Original
This page is a summary of: Long-term neurodevelopment outcome of caffeine versus aminophylline therapy for apnea of prematurity, Journal of Neonatal-Perinatal Medicine, December 2017, IOS Press,
DOI: 10.3233/npm-16147.
You can read the full text:
Contributors
The following have contributed to this page
